Search
for
Sort by
Research 91–120 of 1000+
- Keratinocyte differentiation in psoriatic scalp: morphology and expression of epithelial keratins
- Psoriatic alopecia
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- Psoriatic Skin Lesions Induced by Certolizumab Pegol
- TNF‐inhibitor associated psoriatic alopecia: Diagnostic utility of sebaceous lobule atrophy
- Psoriatic scarring alopecia
- Re-investigating the Basement Membrane Zone of Psoriatic Epidermal Lesions: Is Laminin-511 a New Player in Psoriasis Pathogenesis?
- Marked Reduction of the Number and Individual Volume of Sebaceous Glands in Psoriatic Lesions
- Granulation Tissue that Developed after a Minor Trauma in a Psoriatic Patient on Long-term Etretinate Therapy
- Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease
- Biomechanical Factors in Psoriatic Disease: Defective Repair Exertion as a Potential Cause. Hypothesis Presentation and Literature Review
- Psoriatic Alopecia and Paradoxical Psoriasis Induced by Adalimumab Successfully Treated with Certolizumab: Clinical, Trichoscopic, and in vivo Reflectance Confocal Microscopy Features
- Psoriatic onychopachydermoperiostitis: improvement with etanercept
- Psoriatic Alopecia
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Severe androgenetic alopecia as a proxy of metabolic syndrome in male psoriatic patients older than 59 years
- Localized Hypertrichosis in Subsiding Psoriatic Plaques
- TNF-α Inhibitor-Induced Psoriasis and Psoriatic Alopecia in Adolescent with Ulcerative Colitis: Clinical Case
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Excessive hair growth in a patient with psoriatic erythroderma following secukinumab administration
- Psoriatic Alopecia in a Patient with Systemic Lupus Erythematosus
- Interleukin 17 Expression in Psoriatic Skin Lesions before and after Treatment with Platelet Rich Plasma (PrP)
- Psoriatic Alopecia/Alopecia Areata‐Like Reactions Secondary to Anti‐Tumour Necrosis Factor‐Alpha Therapy
- Ixekizumab improves physical function, quality of life, and work productivity in biologic disease-modifying antirheumatic drug-naive patients with active psoriatic arthritis
- A case of dupilumab-induced psoriatic alopecia
- 0413 IL-17 Inhibitors vs. methotrexate in preventing new-onset psoriatic arthritis in psoriasis patients: a retrospective population-level analysis
- Psoriatic Alopecia: Clinical Features, Pathogenesis, and Emerging Treatment Strategies
- 42276 Long-Term Safety of Ixekizumab Treatment in Adult Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: A Post-hoc Analysis of End-Of-Study Program Data Relating to Major Adverse Cardiovascular Events
- IL-33 Contributes to the Pathological Changes of Hair Follicles in Psoriasis: A Potential Target for Psoriatic Alopecia
- Four-year experience with the preferential derivation care model for multidisciplinary care in patients with psoriasis and psoriatic arthritis